Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 29:41:349.
doi: 10.11604/pamj.2022.41.349.32332. eCollection 2022.

Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute

Ghada Sahraoui  1   2 , Asma Fitouri  1   2   3 , Lamia Charfi  1   2   3 , Maha Driss  1   2   3 , Maher Slimane  1   2 , Monia Hechiche  1   2   3 , Karima Mrad  1   2   3 , Raoudha Doghri  1   2   3
Affiliations

Mucinous borderline ovarian tumors: pathological and prognostic study at Salah Azaiez Institute

Ghada Sahraoui et al. Pan Afr Med J. .

Abstract

Introduction: ovarian Mucinous Borderline Tumors (MBT) are characterized by an epithelial proliferation similar to those of well differentiated adenocarcinomas but are distinguished by the absence of stromal invasion. They are often difficult to diagnose histologically. The aim of the work was to specify the pathological and clinical features and to highlight the prognostic of these tumors.

Methods: study was retrospective including 49 cases of primary ovarian MBT, diagnosed at the Patholgy Department of Salah Azaiez Institute from 1992 to 2019.

Results: median age was 48 years old. Histologically, the cases were divided into 34 cases of pure MBT, 13 cases with intraepithelial carcinoma and 2 cases associating an intraepithelial carcinoma with microinvasion. The majority of our cases were classified FIGO I and only one case FIGO III. Sixteen patients received conservative treatment and 30 received radical treatment. The treatment wasn't specified in three patients. The prognosis was good in the majority of cases. Only one patient had a contralateral recurrence after a follow-up period of three years. There were no significant differences regarding the risk of recurrence and risk factors such as age, gestation, hormonal status, FIGO stage and conservative treatment. We raised this part.

Conclusion: the prognosis of the ovarian MBT is good. However, it is necessary to multiply the samples to avoid missing a carcinomatous focus with an anarchic invasion of the stroma which constitutes a poor prognosis factor. It was changed by these sentences below: the diagnosis of MBT is not easy. Indeed, the distinction of MBT from carcinomas remains the greatest challenge for pathologists. Once this diagnosis is made with certainty, the tumor can be considered to have a good prognosis, especially stage I tumors which are the most common.

Keywords: Mucinous tumor; borderline ovarian tumor; primary tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
microscopic appearance (X400): epithelial coating with tendency to stratification, the nuclei are moderately irregular in appearance, tumor cells exhibit a mucosecretion of the goblet cell type
Figure 2
Figure 2
microscopic appearance (X200): sector of carcinoma in situ
Figure 3
Figure 3
microscopic aspect (X400): Micro-invasion aspect (according to the arrows)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. The WHO . 5th edition. Lyon: IARC; 2020. Classification of Tumours Editorial Board: Female Genital Tumours.
    1. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2016;470(2):125–4. - PMC - PubMed
    1. Sun L, Li N, Song Y, Wang G, Zhao Z, Wu L. Clinicopathologic features and risk factors for recurrence of mucinous borderline ovarian tumors: aretrospective study with follow-up of more than 10 years. Int J Gynecol Cancer. 2018;28(9):1643–9. - PubMed
    1. Chiesa AG, Deavers MT, Veras E, Silva EG, Gershenson D, Malpica A. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change. Int J Gynecol Pathol. 2010;29(2):108–12. - PubMed
    1. Lee KR, Scully RE. Mucinous tumors of the ovary: aclinicopathologic study of196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases With `pseudomyxoma peritonei´. Am J Surg Pathol. 2000;24(11):1447–64. - PubMed